A Phase 1 Clinical Study of E6130 -Clinical Pharmacology Study in Healthy Adult Male Subjects-
Latest Information Update: 27 Mar 2022
Price :
$35 *
At a glance
- Drugs E 6130 (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- Sponsors EA Pharma
- 31 Jul 2018 Status changed to withdrawn prior to enrolment.
- 28 Dec 2017 New trial record